neurodegenerative diseases/fatigue

FIELD OF THE INVENTION The present invention relates to the field of medicine and nutraceuticals, in particular the treatment of neurological and/or neurodegenerative disorders and improvement of brain function. BACKGROUND It has been known for some time now that formation of new neurons from neural

The present invention is concerned with indolin-2-one derivatives of general formula ##STR00002## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from ##STR00003## or the amine group --NR.sup.1R.sup.2 may form together with two neighboring carbon atoms

The present invention is concerned with indolin-2-one derivatives of general formula ##STR00002## wherein A is phenyl or a five or six membered heteroaryl group, containing one or two N atoms, selected from ##STR00003## or the amide group --C(O)--NR.sup.1R.sup.2 may form together with two

The present invention is concerned with indolin-2-one derivatives of general formula ##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from ##STR00005## or the oxygen atom may form together with two neighboring carbon atoms from the group A

The present invention is concerned with indolin-2-one derivatives of general formula ##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from ##STR00005## R.sup.1 is S(O).sub.2lower alkyl, S(O).sub.2NR.sup.4R.sup.5, S(O).sub.2cycloalkyl,

TECHNICAL FIELD This invention relates to an aqueous metal bicarbonate solution, a process of preparing the aqueous metal bicarbonate solution and a method of preventing and treating certain inflammatory diseases, degenerative diseases and viral diseases in mammals. Generally the certain

TECHNICAL FIELD This invention relates to an aqueous metal bicarbonate solution, a process of preparing the aqueous metal bicarbonate solution and a method of preventing and treating certain inflammatory diseases, degenerative diseases and viral diseases in mammals. Generally the certain

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit under 35 U.S.C. .sctn.119(a) of Danish Application No. PA 2013 00427, filed Jul. 14, 2013, entitled Novel Bioactive Alkaloids and Alkaloid Fractions Derivable From Ribes Species, the disclosure of which is incorporated by

FIELD OF THE INVENTION The present invention relates to novel methods of use of specific cytokine antagonists for the treatment of neuropsychiatric and neurological disorders in humans. More particularly, these cytokine antagonists are used in a new treatment of neuropsychiatric and neurologic

FIELD OF THE INVENTION The present invention relates to novel methods of use of specific cytokine antagonists for the treatment of neuropsychiatric and neurological disorders in humans. More particularly, these cytokine antagonists are used in a new treatment of neuropsychiatric and neurologic